AI Issue 8 2017

8 Acquisition International - August 2017 of healthcare, leadership, and business topics, when shared with the right key stakeholders, have changed the way that leaders in our industry think and make decisions about the future of healthcare.” Kelly’s story has touched the lives of others from internal members of our agency to an expansive global network of business leaders, industry executives, scientists, medical experts, and patients worldwide. Danielle then tells us about Kelly’s passion for what she does and the extent to which she is a celebrated thought leader who wants to deliver the healthcare experience possible for patients. “Her ability to harness her ideas and share her profound experiences; encompassing the challenges that she has faced in her journey to understand the wide array of whole disease categories in this world that are ripe for disruption, and the therapies that she has touched and developed with her clients is an impressive testament to the perseverance and passion for healthcare that is inherently rooted in her core internal belief system. “Her purpose has always been to deliver the best and most positive healthcare experience for patients, which has led her to catalyse great innovations for her clients, particularly in disease spaces primarily affecting children, where the medical need is very high indeed. “Kelly is a celebrated thought leader, strategic chief, engaging storyteller, experienced mentor and transformative coach at Simpson Healthcare and values the importance of developing and discovering the talents of her team and understanding what drives them forward to be their best self in life. She strives to bring out the best in her people and in her audiences, as we stand on the edge of disruptive innovation, with the goal being to transform healthcare.” Simpson Healthcare Executives is a diverse scientific learning organisation that was founded by Kelly Simpson-Angelini in 1998. As a global leader in biopharmaceutical communications and consulting, Simpson Healthcare prioritises the patient experience and is dedicated to driving therapeutic innovations forward for their clients. Several years ago, they revisited their mission and vision and transformed it into a purpose statement. Danielle reveals the firm’s purpose, what they do in delivering patient-centred, value-based healthcare and how they collaborate internally to drive disruptively innovative solutions that challenge current expectations in the industry. “Our purpose is why we exist in the world and guides us every moment. Our purpose is to support our clients to share the scientific story of the diseases they touch and therapies they discover for all in need. We believe in our work and in the global reach that we can have for our industry partners as we engage scientific, healthcare, and biopharmaceutical teams in meaningful and disruptive conversation. “We support our clients in their scientific communications through a multitude of marketing and interactive communications channels that are specifically tailored to achieve each of our clients’ strategic goals. Our clients include Big Pharma, as well as smaller pharmaceutical and biotechnology companies, some of which have smaller and more targeted portfolios of products. As do our clients, Simpson Healthcare prioritises the patient experience, and we believe in delivering patient-centred, value- based healthcare. We believe that it is essential to think disruptively to understand and discover what patients may be expecting and experiencing as they receive care and undergo treatment. “Our goal is to create more positive healthcare experiences, so that patients can feel better and have brighter health outlooks. It is our privilege to work with our prestigious clients as we understand and develop the scientific story that our client needs to tell. We ensure that we have the right members on our teams and we think disruptively about the delivery of our story to our audience, which means that we pull through the experience of our organisation with previous similar challenges. We believe that everyone on our team should know the client’s goals and how our story will support it. “Internally, we collaborate to drive disruptively innovative solutions that challenge current expectations in our industry using a wide array of lenses and perspectives as we bring to bear the larger context of healthcare. Our organisation has a wide depth of experience in a diverse, broad array of therapeutic areas, including oncology, respiratory, severe asthma, rare disease, infectious disease, cardiovascular, stroke, gastrointestinal, and many more. Our internal therapeutic fluency is systemically high and well-maintained, as we pull through the experience of our members, and what it means to be a prominent learning organisation in healthcare communications to catalyse transformation in our industry for our clients.” One of the most ground-breaking, expansive healthcare knowledge ventures that Kelly Simpson- Angelini has pioneered is the development of is the new line of FUTURING work that the firm has implemented with many of their big pharma clients. This service offering was designed and launched through the collaborations of their experienced medical team and under Kelly’s strategic guidance, and has been implemented with the purpose and intent of catalysing disruptive transformation in the healthcare industry into the next decade. Danielle goes on to develop this interesting point in further detail, adding how Kelly Simpson-Angelini has designed is a dynamic, transformational leadership team of senior members. “The value in looking ahead and ‘FUTURING’, cannot be overstated as it allows space for conversation among key stakeholders about potential ‘FUTURE STATES’ that takes us beyond current assumptions that we may have. During this process, we envision potential ‘BEST and WORST FUTURES’, without any reference to the present day. We imagine what could be, without current constraints. The value is in the perspective generated from the exercise, which creates a different conversation around decisions that we must make in the present day. “Once the FUTURES have been imagined, the drivers to reach those FUTURES are identified, which helps to identify opportunities to shape a DESIRED FUTURE’ or avoid an impact from an UNDESIRABLE FUTURE’. Throughout, we gather and analyse global datasets, policies, practices, and other influential variables that could influence or disrupt key markets in healthcare across a longer 10-20-year vision for the FUTURE. These inventories are a starting point for change based on the identified opportunities from this process. “As such, the leadership team that Kelly Simpson- Angelini has designed is a dynamic, transformational leadership team of senior members who are patient-centred, dynamic and highly collaborative, elite group of business and scientific members who have a high level of therapeutic fluency and are well-